Compare CARR & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CARR | BSX |
|---|---|---|
| Founded | 2019 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 65.8B |
| IPO Year | 2020 | 2010 |
| Metric | CARR | BSX |
|---|---|---|
| Price | $63.95 | $48.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 22 |
| Target Price | $70.62 | ★ $93.18 |
| AVG Volume (30 Days) | 6.9M | ★ 17.5M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | 0.28 | ★ 1.51 |
| Revenue | ★ $21,747,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $2.91 | $11.85 |
| Revenue Next Year | $5.37 | $10.16 |
| P/E Ratio | $233.68 | ★ $31.62 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $50.24 | $42.20 |
| 52 Week High | $76.76 | $109.50 |
| Indicator | CARR | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 64.23 |
| Support Level | $65.77 | $47.17 |
| Resistance Level | $69.53 | $50.14 |
| Average True Range (ATR) | 2.12 | 1.54 |
| MACD | -0.05 | 0.68 |
| Stochastic Oscillator | 63.30 | 96.00 |
Carrier Global, spun out of United Technologies in 2020, manufactures and services commercial and residential HVAC systems and transportation refrigeration solutions under its flagship Carrier brand, as well as Bryant, Payne, Heil, and others across various price points. In 2024, Carrier acquired Viessmann Climate Solutions to expand its footprint in Europe with heat pumps, boilers, and solar PV equipment. Proceeds from the sale of Carrier's fire and security (Honeywell) and commercial refrigeration (Haier) businesses reduced debt and focused the company on global HVAC and refrigeration solutions. Carrier generates 75% of sales from equipment and 25% from parts and services. The company derives 50% of revenue from the US, 30% from Europe, and 20% from the Asia-Pacific region.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.